| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > RSS > RSS Success Depends on a Content Strategy |
|
Just Other Articles - RSS Success Depends on a Content Strategy
RSS is the hot messaging idea gaining the attention of PR and marketing folks alike everywhere. And while t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hey struggle with questions such as “what is RSS?” and “How do we implement this on our websites and blogs? ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ,” many are missing the point. It’s not so much about the technology as it is about the content. Bill Fre lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ch at Myst Technology has been building Enterprise RSS sites for years. In a recent interview with Inkblot here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he said, “oddly enough, understanding your customer’s content requirements is tougher than the technical ch d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro allenges associated with syndication. It’s relatively easy to create feeds. It’s very difficult to create a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc feed that a segment of your audience cannot live without - and that’s the objective.” There are many servi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ces out there that can add an RSS feed or conversion to your website. But what you put in the feed determin nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically es your success. Far too many companies have not thought this through enough and they don’t have an enterp and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ise-wide content strategy. There also seems to be a disconnect between online and offline content. Perhaps ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi it’s because they are still trying to cope with what all this hot technology is and how it works, rather th ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a an what should be in it. Instead of figuring on how to monetize feeds with ads, we should be concentrating dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod on how to create that feed they can’t live without. Who would want to read an aggregated feed of hundreds cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin of press releases from a newswire site? What you need to do is figure out who your audiences are and what i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nterests them. You may only have 100 people reading your feed, but if they are the right 100 people, you’re t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel home free. The recent study from the Ponemon Institute revealed that consumers do want to get messages fro ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust m companies, but they want it to be relevant, based on previous purchase behavior and they want to be in co y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ntrol of the delivery method. That’s a perfect RSS strategy right there. The more things change, the more . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hey stay the same. Segmenting audiences and creating content specifically for one group is one of the most elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip basic PR and marketing techniques. Apply it to your RSS content strategy and you’ll get spectacular results tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Starting A Business: Sole Proprietor Or Corporation? Sales Hint: USE EVERYTHING, Including Rejection! Do We Need To Prepare A Funeral For Internet Marketing?
|